CSL

高管在CSL变化

David Lamont, Chief Financial Officer, 将于 202010月30 退休  (新闻发布的2020六月17号).

创建提醒
跟踪 CSL 的高管变动

是其中之一......

• Forbes Global 2000 (#610).

CSL 搜索最多的简介

• Paul Perreault, Chief Executive Officer and Managing Director
• Megan Clark, Director
• Marie McDonald, Director

单击任一高管查看其简介 >

Latest M&A news in 药店.

Tilray and Aphria have announced they will merge (posted on 12月 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on 12月 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on 11月 18, 2020).

药店 行业的其他推荐联系人

• Pfizer 企业 Albert Bourla - Chief Executive Officer and Chairman of the Board
• Roche 企业 Per-Olof Attinger - Executive Committee Secretary
• Dirk Rossmann 企业 Alice Schardt-Rossmann - Managing Director

了解更多有关药店行业的信息 >

有关 CSL 的最新新闻

20201108 CSL Commences Manufacturing of University of Oxford/AstraZeneca Vaccine Candidate in Melbourne
CSL Named as One of the World’s Best Employers
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
20200625 CSL Behring agrees to acquire gene therapy candidate from uniQure
20200122 Forbes Magazine Ranks CSL Among Best Employers for Diversity Press Release

CSL 在 维基百科、谷歌新闻 和 雅虎财经

CSL 在 LinkedIn、叽叽喳喳 和 YouTube

CSL 拥有 12 家子公司，其中包括 CSL Behring、CSL Behring APAC 和 CSL Behring Austria。 CSL 拥有 2,035 家竞争者，其中包括 Johnson & Johnson (美国(美洲))、Pfizer (美国(美洲)) 和 Roche (瑞士)。

通过电子邮件联系联系该企业高管，包括 Paul Perreault

致电CSL，电话：+61 39...

查看组织结构图

Register to receive your alert

报告错误